Rossari Biotech gets nod to acquire Tristar Intermediates

19 Jul 2021 Evaluate

Rossari Biotech’s board has approved the acquisition of Tristar Intermediates at an enterprise value of Rs 120 crore. A move which will help Rossari Biotech expand its product portfolio, primarily in the personal care segment.

As per the agreement and subject to customary closing conditions, Rossari will be acquiring 100 percent equity share capital of Tristar Intermediates. 76 percent of the equity share capital will be acquired upon closure of the transaction, and the balance 24 percent over the next three years.

Rossari Biotech is a specialty chemicals manufacturing firm with focus on home and personal care, performance chemicals, textile specialty chemicals and animal health and nutrition products. Apart from India, it has operations in 17 countries including Vietnam, Bangladesh and Mauritius.

Rossari Biotech Share Price

690.70 10.35 (1.52%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1055.30
SRF 2309.10
Pidilite Inds. 3110.05
Aarti Inds 634.10
Gujarat Fluorochemic 2980.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.